Share Price and Basic Stock Data
Last Updated: January 3, 2026, 1:31 pm
| PEG Ratio | 29.38 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Covidh Technologies Ltd operates within the IT Consulting and Software industry, with its stock currently priced at ₹17.6 and a market capitalization of ₹14.8 Cr. The company has reported zero sales from September 2022 through to December 2024, indicating a significant challenge in revenue generation. The last reported sales figure was ₹0.00 for the trailing twelve months, highlighting a complete lack of operational income. This absence of sales, coupled with a declining trend from previous fiscal years, where the highest recorded sales were ₹28.92 Cr in March 2018, raises concerns about the company’s ability to regain its footing in the competitive IT landscape. The operational difficulties are further exacerbated by escalating expenses, which have been consistently reported, leading to operating losses across the same period. The last recorded operating profit was a loss of ₹0.13 Cr for the financial year ending March 2025, emphasizing ongoing financial strain.
Profitability and Efficiency Metrics
Covidh Technologies Ltd’s profitability metrics paint a concerning picture, with a reported net profit of ₹0.15 Cr, translating into a P/E ratio of 98.9, which is significantly high compared to typical industry standards. The company’s return on capital employed (ROCE) stood at 19.0%, which, while positive, does not offset the operational challenges faced due to zero revenue. Operating profit margins have consistently been negative, with the last reported margin at -0.13 Cr for March 2025. The interest coverage ratio (ICR) is alarmingly low at -0.24x, indicating that the company is struggling to meet its interest obligations, a crucial factor for long-term sustainability. Moreover, the cash conversion cycle metrics are absent, suggesting that the company may not have effective cash management strategies in place, adding to the overall financial distress observed.
Balance Sheet Strength and Financial Ratios
The balance sheet of Covidh Technologies Ltd reveals significant weaknesses, particularly in terms of its reserves and borrowings. The company reported reserves of -₹0.43 Cr, indicating a deficit which raises red flags regarding financial health. Borrowings stood at ₹1.62 Cr, highlighting reliance on debt financing without corresponding revenue to support repayment. The price-to-book value ratio is at 6.13x, suggesting that investors are pricing in significant risk given the company’s financial instability. Furthermore, the company’s total liabilities have decreased to ₹1.55 Cr as of September 2025, but the reduction in liabilities does not compensate for the lack of operational income. The high debt-to-equity ratio indicates that the company is heavily leveraged, which could pose risks in a tightening credit environment.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Covidh Technologies Ltd has witnessed significant changes, particularly in the promoter and public ownership stakes. As of November 2025, promoters hold 3.57% of the company, down from 100% earlier in 2023, while public ownership has surged to 96.44%. This drastic shift suggests a possible divestment by promoters, raising concerns about their confidence in the company’s future. The number of shareholders has also increased substantially from 1 in March 2023 to 1,031 by November 2025, indicating growing interest or perhaps speculative trading activity among the public. However, the lack of Foreign Institutional Investors (FIIs) and Domestic Institutional Investors (DIIs) involvement points to a lack of institutional confidence, likely influenced by the company’s financial struggles and operational challenges. This dynamic could lead to volatility in stock price movements as market perceptions shift.
Outlook, Risks, and Final Insight
Looking ahead, Covidh Technologies Ltd faces a precarious outlook characterized by significant operational risks. The absence of revenue generation poses a fundamental challenge, and without a clear strategy to revitalize sales, the company may continue to struggle. However, the recorded ROCE of 19.0% indicates potential for profitability if operational hurdles can be overcome. Risks include the high debt levels, which could become unsustainable if the company fails to generate income, and the volatility associated with its shifting shareholding structure. Conversely, a strategic pivot towards revenue-generating ventures or cost management could improve its financial position. If the company can stabilize its operations and regain investor confidence, it may find pathways for recovery. The interplay between operational efficiency and financial management will be critical in determining Covidh Technologies’ future trajectory in the IT sector.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Visesh Infotecnics Ltd | 125 Cr. | 0.33 | / | 1.11 | 0.00 % | 2.21 % | 2.23 % | 1.00 | |
| Mudunuru Ltd | 59.2 Cr. | 18.7 | 18.7/4.43 | 0.20 | 0.00 % | 27.0 % | 90.7 % | 2.00 | |
| Naapbooks Ltd | 149 Cr. | 138 | 194/99.8 | 22.8 | 36.4 | 0.00 % | 23.6 % | 17.1 % | 10.0 |
| IB Infotech Enterprises Ltd | 38.3 Cr. | 299 | 310/140 | 27.4 | 26.7 | 0.33 % | 38.5 % | 35.4 % | 10.0 |
| Hit Kit Global Solutions Ltd | 5.71 Cr. | 1.06 | 1.73/0.91 | 2.47 | 0.00 % | 2.14 % | 2.15 % | 2.00 | |
| Industry Average | 20,271.35 Cr | 554.45 | 88.36 | 123.78 | 0.55% | 14.88% | 20.92% | 6.84 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Expenses | 0.06 | 0.02 | 0.02 | 0.01 | 0.02 | 0.01 | 0.07 | 0.01 | 0.01 | 0.07 | 0.04 | 0.02 | 0.00 |
| Operating Profit | -0.06 | -0.02 | -0.02 | -0.01 | -0.02 | -0.01 | -0.07 | -0.01 | -0.01 | -0.07 | -0.04 | -0.02 | 0.00 |
| OPM % | |||||||||||||
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.27 | 0.00 | 0.01 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | -0.06 | -0.02 | -0.02 | -0.01 | -0.02 | -0.01 | -0.07 | -0.01 | -0.01 | -0.07 | 0.23 | -0.02 | 0.01 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit | -0.06 | -0.02 | -0.02 | -0.01 | -0.02 | -0.01 | -0.07 | -0.01 | -0.01 | -0.07 | 0.23 | -0.02 | 0.01 |
| EPS in Rs | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.08 | -0.01 | -0.01 | -0.08 | 0.27 | -0.02 | 0.01 |
Last Updated: December 27, 2025, 10:31 am
Below is a detailed analysis of the quarterly data for Covidh Technologies Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Expenses, as of Sep 2025, the value is 0.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.02 Cr. (Jun 2025) to 0.00 Cr., marking a decrease of 0.02 Cr..
- For Operating Profit, as of Sep 2025, the value is 0.00 Cr.. The value appears strong and on an upward trend. It has increased from -0.02 Cr. (Jun 2025) to 0.00 Cr., marking an increase of 0.02 Cr..
- For OPM %, as of Sep 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00%.
- For Other Income, as of Sep 2025, the value is 0.01 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Jun 2025) to 0.01 Cr., marking an increase of 0.01 Cr..
- For Interest, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Depreciation, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 0.01 Cr.. The value appears strong and on an upward trend. It has increased from -0.02 Cr. (Jun 2025) to 0.01 Cr., marking an increase of 0.03 Cr..
- For Tax %, as of Sep 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00%.
- For Net Profit, as of Sep 2025, the value is 0.01 Cr.. The value appears strong and on an upward trend. It has increased from -0.02 Cr. (Jun 2025) to 0.01 Cr., marking an increase of 0.03 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.01. The value appears strong and on an upward trend. It has increased from -0.02 (Jun 2025) to 0.01, marking an increase of 0.03.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:54 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 23.32 | 10.90 | 25.50 | 21.36 | 28.92 | 12.30 | 2.13 | 2.13 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Expenses | 23.14 | 10.28 | 25.14 | 20.92 | 28.46 | 11.98 | 2.19 | 0.19 | 0.11 | 0.11 | 0.09 | 0.13 | 0.13 |
| Operating Profit | 0.18 | 0.62 | 0.36 | 0.44 | 0.46 | 0.32 | -0.06 | 1.94 | -0.11 | -0.11 | -0.09 | -0.13 | -0.13 |
| OPM % | 0.77% | 5.69% | 1.41% | 2.06% | 1.59% | 2.60% | -2.82% | 91.08% | |||||
| Other Income | 0.00 | 0.00 | -12.61 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.27 | 0.28 |
| Interest | 0.00 | 0.00 | 0.16 | 0.20 | 0.27 | 0.23 | 0.22 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.10 | 0.50 | 0.08 | 0.21 | 0.15 | 0.08 | 0.12 | 0.12 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.08 | 0.12 | -12.49 | 0.03 | 0.04 | 0.01 | -0.40 | 1.80 | -0.11 | -0.11 | -0.09 | 0.14 | 0.15 |
| Tax % | 50.00% | 0.00% | 0.40% | 100.00% | 25.00% | 200.00% | 5.00% | 1.11% | 0.00% | 0.00% | 0.00% | 0.00% | |
| Net Profit | 0.04 | 0.12 | -12.54 | 0.00 | 0.04 | -0.02 | -0.42 | 1.78 | -0.11 | -0.11 | -0.09 | 0.14 | 0.15 |
| EPS in Rs | 0.00 | 0.00 | -0.46 | 0.00 | 0.00 | -0.00 | -0.02 | 0.06 | -0.00 | -0.00 | -0.11 | 0.17 | 0.18 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 200.00% | -10550.00% | 100.00% | -150.00% | -2000.00% | 523.81% | -106.18% | 0.00% | 18.18% | 255.56% |
| Change in YoY Net Profit Growth (%) | 0.00% | -10750.00% | 10650.00% | -250.00% | -1850.00% | 2523.81% | -629.99% | 106.18% | 18.18% | 237.37% |
Covidh Technologies Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 18% |
| 3 Years: | 48% |
| TTM: | 218% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -5% |
| 5 Years: | % |
| 3 Years: | 60% |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Last Updated: September 5, 2025, 3:06 pm
Balance Sheet
Last Updated: December 10, 2025, 4:07 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10.60 | 10.60 | 10.60 | 10.60 | 10.60 | 10.60 | 10.60 | 10.60 | 0.30 | 0.30 | 0.32 | 0.32 | 0.32 |
| Reserves | 2.33 | 2.44 | -10.10 | -10.09 | -10.05 | -10.07 | -10.49 | -10.71 | -0.31 | -0.42 | -0.54 | -0.42 | -0.43 |
| Borrowings | 4.28 | 4.97 | 6.15 | 6.83 | 7.49 | 7.53 | 6.56 | 2.02 | 0.00 | 0.13 | 0.18 | 1.61 | 1.62 |
| Other Liabilities | 3.56 | 2.54 | 4.61 | 5.57 | 8.19 | 4.12 | 3.81 | 2.59 | 0.02 | 0.04 | 0.10 | 0.05 | 0.04 |
| Total Liabilities | 20.77 | 20.55 | 11.26 | 12.91 | 16.23 | 12.18 | 10.48 | 4.50 | 0.01 | 0.05 | 0.06 | 1.56 | 1.55 |
| Fixed Assets | 4.75 | 6.65 | 0.48 | 0.44 | 0.45 | 0.75 | 0.62 | 0.43 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CWIP | 3.08 | 1.96 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 4.32 | 4.20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 8.62 | 7.74 | 10.78 | 12.47 | 15.78 | 11.43 | 9.86 | 4.07 | 0.01 | 0.05 | 0.06 | 1.56 | 1.55 |
| Total Assets | 20.77 | 20.55 | 11.26 | 12.91 | 16.23 | 12.18 | 10.48 | 4.50 | 0.01 | 0.05 | 0.06 | 1.56 | 1.55 |
Below is a detailed analysis of the balance sheet data for Covidh Technologies Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 0.32 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.32 Cr..
- For Reserves, as of Sep 2025, the value is -0.43 Cr.. The value appears to be worsening (becoming more negative). It has deteriorated from -0.42 Cr. (Mar 2025) to -0.43 Cr., marking a decline of 0.01 Cr..
- For Borrowings, as of Sep 2025, the value is 1.62 Cr.. The value appears to be increasing, which may not be favorable. However, Reserves are negative, which is a major warning sign. It has increased from 1.61 Cr. (Mar 2025) to 1.62 Cr., marking an increase of 0.01 Cr..
- For Other Liabilities, as of Sep 2025, the value is 0.04 Cr.. The value appears to be improving (decreasing). It has decreased from 0.05 Cr. (Mar 2025) to 0.04 Cr., marking a decrease of 0.01 Cr..
- For Total Liabilities, as of Sep 2025, the value is 1.55 Cr.. The value appears to be improving (decreasing). It has decreased from 1.56 Cr. (Mar 2025) to 1.55 Cr., marking a decrease of 0.01 Cr..
- For Fixed Assets, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1.55 Cr.. The value appears to be declining and may need further review. It has decreased from 1.56 Cr. (Mar 2025) to 1.55 Cr., marking a decrease of 0.01 Cr..
- For Total Assets, as of Sep 2025, the value is 1.55 Cr.. The value appears to be declining and may need further review. It has decreased from 1.56 Cr. (Mar 2025) to 1.55 Cr., marking a decrease of 0.01 Cr..
However, the Borrowings (1.62 Cr.) are higher than the Reserves (-0.43 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -4.10 | -4.35 | -5.79 | -6.39 | -7.03 | -7.21 | -6.62 | -0.08 | -0.11 | -0.24 | -0.27 | -1.74 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 130.54 | 192.55 | 122.81 | 174.64 | 177.96 | 297.34 | 1,470.28 | 498.66 | ||||
| Inventory Days | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 130.54 | 192.55 | 122.81 | 174.64 | 177.96 | 297.34 | 1,470.28 | 498.66 | ||||
| Working Capital Days | 79.35 | 174.46 | 65.13 | 91.59 | 73.58 | 170.33 | 1,041.88 | 260.47 | ||||
| ROCE % | 0.51% | 0.68% | 2.27% | 3.29% | 4.03% | 2.98% | -2.44% | 42.42% | -11.58% | 19.05% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -0.39 | -0.04 | 0.01 | -0.03 | -12.66 |
| Diluted EPS (Rs.) | -0.39 | -0.04 | 0.01 | -0.03 | -12.66 |
| Cash EPS (Rs.) | -0.27 | 0.07 | 0.18 | 0.21 | -12.53 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 0.10 | 0.46 | 0.50 | 0.49 | 0.52 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 0.10 | 0.46 | 0.50 | 0.49 | 0.52 |
| Revenue From Operations / Share (Rs.) | 2.01 | 24.23 | 31.67 | 22.68 | 24.05 |
| PBDIT / Share (Rs.) | -0.05 | 0.45 | 0.44 | 0.43 | 0.19 |
| PBIT / Share (Rs.) | -0.16 | 0.34 | 0.26 | 0.19 | 0.06 |
| PBT / Share (Rs.) | -0.37 | -0.01 | 0.01 | 0.00 | 0.06 |
| Net Profit / Share (Rs.) | -0.39 | -0.04 | 0.01 | -0.03 | -12.66 |
| NP After MI And SOA / Share (Rs.) | -0.39 | -0.04 | 0.01 | -0.03 | -12.66 |
| PBDIT Margin (%) | -2.57 | 1.86 | 1.40 | 1.92 | 0.79 |
| PBIT Margin (%) | -8.34 | 1.40 | 0.84 | 0.84 | 0.25 |
| PBT Margin (%) | -18.79 | -0.07 | 0.04 | 0.00 | 0.25 |
| Net Profit Margin (%) | -19.64 | -0.16 | 0.02 | -0.14 | -52.63 |
| NP After MI And SOA Margin (%) | -19.64 | -0.16 | 0.02 | -0.14 | -52.63 |
| Return on Networth / Equity (%) | -372.77 | -8.99 | 1.44 | -6.72 | -2425.18 |
| Return on Capital Employeed (%) | -2.65 | 4.20 | 3.42 | 2.63 | 1.00 |
| Return On Assets (%) | -4.00 | -0.24 | 0.03 | -0.20 | -92.73 |
| Long Term Debt / Equity (X) | 58.39 | 16.75 | 14.75 | 13.84 | 10.66 |
| Total Debt / Equity (X) | 58.39 | 22.04 | 18.07 | 16.79 | 13.57 |
| Asset Turnover Ratio (%) | 0.15 | 0.76 | 1.75 | 1.56 | 1.41 |
| Current Ratio (X) | 2.62 | 1.84 | 1.66 | 1.78 | 1.72 |
| Quick Ratio (X) | 2.62 | 1.84 | 1.66 | 1.78 | 1.72 |
| Interest Coverage Ratio (X) | -0.24 | 1.26 | 1.75 | 2.26 | 0.00 |
| Interest Coverage Ratio (Post Tax) (X) | -0.87 | 0.88 | 1.03 | 0.82 | 0.00 |
| Enterprise Value (Cr.) | -1.33 | 10.82 | 11.01 | 11.58 | 13.81 |
| EV / Net Operating Revenue (X) | -0.62 | 0.42 | 0.32 | 0.48 | 0.54 |
| EV / EBITDA (X) | 24.26 | 22.58 | 23.32 | 25.02 | 68.50 |
| MarketCap / Net Operating Revenue (X) | 0.32 | 0.02 | 0.04 | 0.11 | 0.24 |
| Price / BV (X) | 6.13 | 1.25 | 2.86 | 5.56 | 11.48 |
| Price / Net Operating Revenue (X) | 0.32 | 0.02 | 0.04 | 0.11 | 0.24 |
| EarningsYield | -0.60 | -0.07 | 0.00 | -0.01 | -2.12 |
After reviewing the key financial ratios for Covidh Technologies Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 20, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 19) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 20, the value is -0.39. This value is below the healthy minimum of 5. It has decreased from -0.04 (Mar 19) to -0.39, marking a decrease of 0.35.
- For Diluted EPS (Rs.), as of Mar 20, the value is -0.39. This value is below the healthy minimum of 5. It has decreased from -0.04 (Mar 19) to -0.39, marking a decrease of 0.35.
- For Cash EPS (Rs.), as of Mar 20, the value is -0.27. This value is below the healthy minimum of 3. It has decreased from 0.07 (Mar 19) to -0.27, marking a decrease of 0.34.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 20, the value is 0.10. It has decreased from 0.46 (Mar 19) to 0.10, marking a decrease of 0.36.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 20, the value is 0.10. It has decreased from 0.46 (Mar 19) to 0.10, marking a decrease of 0.36.
- For Revenue From Operations / Share (Rs.), as of Mar 20, the value is 2.01. It has decreased from 24.23 (Mar 19) to 2.01, marking a decrease of 22.22.
- For PBDIT / Share (Rs.), as of Mar 20, the value is -0.05. This value is below the healthy minimum of 2. It has decreased from 0.45 (Mar 19) to -0.05, marking a decrease of 0.50.
- For PBIT / Share (Rs.), as of Mar 20, the value is -0.16. This value is below the healthy minimum of 0. It has decreased from 0.34 (Mar 19) to -0.16, marking a decrease of 0.50.
- For PBT / Share (Rs.), as of Mar 20, the value is -0.37. This value is below the healthy minimum of 0. It has decreased from -0.01 (Mar 19) to -0.37, marking a decrease of 0.36.
- For Net Profit / Share (Rs.), as of Mar 20, the value is -0.39. This value is below the healthy minimum of 2. It has decreased from -0.04 (Mar 19) to -0.39, marking a decrease of 0.35.
- For NP After MI And SOA / Share (Rs.), as of Mar 20, the value is -0.39. This value is below the healthy minimum of 2. It has decreased from -0.04 (Mar 19) to -0.39, marking a decrease of 0.35.
- For PBDIT Margin (%), as of Mar 20, the value is -2.57. This value is below the healthy minimum of 10. It has decreased from 1.86 (Mar 19) to -2.57, marking a decrease of 4.43.
- For PBIT Margin (%), as of Mar 20, the value is -8.34. This value is below the healthy minimum of 10. It has decreased from 1.40 (Mar 19) to -8.34, marking a decrease of 9.74.
- For PBT Margin (%), as of Mar 20, the value is -18.79. This value is below the healthy minimum of 10. It has decreased from -0.07 (Mar 19) to -18.79, marking a decrease of 18.72.
- For Net Profit Margin (%), as of Mar 20, the value is -19.64. This value is below the healthy minimum of 5. It has decreased from -0.16 (Mar 19) to -19.64, marking a decrease of 19.48.
- For NP After MI And SOA Margin (%), as of Mar 20, the value is -19.64. This value is below the healthy minimum of 8. It has decreased from -0.16 (Mar 19) to -19.64, marking a decrease of 19.48.
- For Return on Networth / Equity (%), as of Mar 20, the value is -372.77. This value is below the healthy minimum of 15. It has decreased from -8.99 (Mar 19) to -372.77, marking a decrease of 363.78.
- For Return on Capital Employeed (%), as of Mar 20, the value is -2.65. This value is below the healthy minimum of 10. It has decreased from 4.20 (Mar 19) to -2.65, marking a decrease of 6.85.
- For Return On Assets (%), as of Mar 20, the value is -4.00. This value is below the healthy minimum of 5. It has decreased from -0.24 (Mar 19) to -4.00, marking a decrease of 3.76.
- For Long Term Debt / Equity (X), as of Mar 20, the value is 58.39. This value exceeds the healthy maximum of 1. It has increased from 16.75 (Mar 19) to 58.39, marking an increase of 41.64.
- For Total Debt / Equity (X), as of Mar 20, the value is 58.39. This value exceeds the healthy maximum of 1. It has increased from 22.04 (Mar 19) to 58.39, marking an increase of 36.35.
- For Asset Turnover Ratio (%), as of Mar 20, the value is 0.15. It has decreased from 0.76 (Mar 19) to 0.15, marking a decrease of 0.61.
- For Current Ratio (X), as of Mar 20, the value is 2.62. This value is within the healthy range. It has increased from 1.84 (Mar 19) to 2.62, marking an increase of 0.78.
- For Quick Ratio (X), as of Mar 20, the value is 2.62. This value exceeds the healthy maximum of 2. It has increased from 1.84 (Mar 19) to 2.62, marking an increase of 0.78.
- For Interest Coverage Ratio (X), as of Mar 20, the value is -0.24. This value is below the healthy minimum of 3. It has decreased from 1.26 (Mar 19) to -0.24, marking a decrease of 1.50.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 20, the value is -0.87. This value is below the healthy minimum of 3. It has decreased from 0.88 (Mar 19) to -0.87, marking a decrease of 1.75.
- For Enterprise Value (Cr.), as of Mar 20, the value is -1.33. It has decreased from 10.82 (Mar 19) to -1.33, marking a decrease of 12.15.
- For EV / Net Operating Revenue (X), as of Mar 20, the value is -0.62. This value is below the healthy minimum of 1. It has decreased from 0.42 (Mar 19) to -0.62, marking a decrease of 1.04.
- For EV / EBITDA (X), as of Mar 20, the value is 24.26. This value exceeds the healthy maximum of 15. It has increased from 22.58 (Mar 19) to 24.26, marking an increase of 1.68.
- For MarketCap / Net Operating Revenue (X), as of Mar 20, the value is 0.32. This value is below the healthy minimum of 1. It has increased from 0.02 (Mar 19) to 0.32, marking an increase of 0.30.
- For Price / BV (X), as of Mar 20, the value is 6.13. This value exceeds the healthy maximum of 3. It has increased from 1.25 (Mar 19) to 6.13, marking an increase of 4.88.
- For Price / Net Operating Revenue (X), as of Mar 20, the value is 0.32. This value is below the healthy minimum of 1. It has increased from 0.02 (Mar 19) to 0.32, marking an increase of 0.30.
- For EarningsYield, as of Mar 20, the value is -0.60. This value is below the healthy minimum of 5. It has decreased from -0.07 (Mar 19) to -0.60, marking a decrease of 0.53.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Covidh Technologies Ltd:
- Net Profit Margin: -19.64%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -2.65% (Industry Average ROCE: 14.88%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -372.77% (Industry Average ROE: 20.92%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -0.87
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.62
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 98.9 (Industry average Stock P/E: 88.36)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 58.39
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -19.64%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| IT Consulting & Software | B-2, Plot: 797/A, Sai Krishna Building, Hyderabad Telangana 500033 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mrs. Jayshree Suresh Jain | Managing Director |
| Mr. Jitendra Prabhakar | Executive Director |
| Mr. Mangina Srinivas Rao | Independent Director |
| Ms. Apurva Pradeep Joshi | Independent Director |
FAQ
What is the intrinsic value of Covidh Technologies Ltd?
Covidh Technologies Ltd's intrinsic value (as of 03 January 2026) is ₹1.57 which is 91.08% lower the current market price of ₹17.60, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹14.8 Cr. market cap, FY2025-2026 high/low of ₹17.6/1.90, reserves of ₹-0.43 Cr, and liabilities of ₹1.55 Cr.
What is the Market Cap of Covidh Technologies Ltd?
The Market Cap of Covidh Technologies Ltd is 14.8 Cr..
What is the current Stock Price of Covidh Technologies Ltd as on 03 January 2026?
The current stock price of Covidh Technologies Ltd as on 03 January 2026 is ₹17.6.
What is the High / Low of Covidh Technologies Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Covidh Technologies Ltd stocks is ₹17.6/1.90.
What is the Stock P/E of Covidh Technologies Ltd?
The Stock P/E of Covidh Technologies Ltd is 98.9.
What is the Book Value of Covidh Technologies Ltd?
The Book Value of Covidh Technologies Ltd is 0.13.
What is the Dividend Yield of Covidh Technologies Ltd?
The Dividend Yield of Covidh Technologies Ltd is 0.00 %.
What is the ROCE of Covidh Technologies Ltd?
The ROCE of Covidh Technologies Ltd is 19.0 %.
What is the ROE of Covidh Technologies Ltd?
The ROE of Covidh Technologies Ltd is %.
What is the Face Value of Covidh Technologies Ltd?
The Face Value of Covidh Technologies Ltd is 10.0.